NCT06671743

Brief Summary

The goal of this clinical trial is to compare the efficacy of preoperative administration of alpha-chemo-trypsin, ibuprofen, and acetaminophen in managing post-endodontic pain in patients with symptomatic irreversible pulpitis. The main question it aims to answer is: What is the efficacy of preoperative administration of alpha-chemo-trypsin, ibuprofen, and acetaminophen in managing post-endodontic pain in patients with symptomatic irreversible pulpitis? Participants will undergo root canal treatment after premedication. Researchers will compare \[alpha-chemo-trypsin, ibuprofen, and acetaminophen\] to see the intensity of post-endodontic pain.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at below P25 for phase_3

Timeline
6mo left

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Sep 2024Nov 2026

Study Start

First participant enrolled

September 1, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 30, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 4, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

November 4, 2024

Status Verified

November 1, 2024

Enrollment Period

1.8 years

First QC Date

October 30, 2024

Last Update Submit

November 1, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Post-endodontic pain score

    Post operative pain score will be recorded using the visual analogue pain scale, where the patient will mark a point on a 10-cm line representing a continuum from 'no pain' to 'worst pain imaginable.

    6 hours

  • Post-endodontic pain score

    Post operative pain score will be recorded using the visual analogue pain scale, where the patient will mark a point on a 10-cm line representing a continuum from 'no pain' to 'worst pain imaginable.

    12 hours

  • Post-endodontic pain score

    Post operative pain score will be recorded using the visual analogue pain scale, where the patient will mark a point on a 10-cm line representing a continuum from 'no pain' to 'worst pain imaginable.

    24 hours

  • Post-endodontic pain score

    Post operative pain score will be recorded using the visual analogue pain scale, where the patient will mark a point on a 10-cm line representing a continuum from 'no pain' to 'worst pain imaginable.

    48 hours

Study Arms (4)

trypsin-chymotrypsin

EXPERIMENTAL
Procedure: Root canal treatment

Ibuprofen

ACTIVE COMPARATOR
Procedure: Root canal treatment

paracetamol

ACTIVE COMPARATOR
Procedure: Root canal treatment

placebo

PLACEBO COMPARATOR
Procedure: Root canal treatment

Interventions

History of presenting illness will be recorded and vitality testing will be done in addition to pre-operative radiograph. Patient will read and sign the consent form. Pre-operative pain score will be recorded using visual analogue scale. The patient will take the preoperative medication 1 hour prior to the procedure. The patient will receive 1 cartridge of LA with inferior alveolar nerve block (2% lidocaine 1:80000) and a rubber dam will be used for isolation. Access cavity will be prepared and working length will be determined. Cleaning and shaping of the root canal system will be performed followed by obturation using a standardized protocol followed by final coronal restoration. Postoperative pain score will be recorded at the 6, 12, 24, and 48 hours using visual analogue pain scale.

Ibuprofenparacetamolplacebotrypsin-chymotrypsin

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Eligibility for root canal treatment Patients diagnosed with symptomatic irreversible pulpitis with normal apical tissue in mandibular molars

You may not qualify if:

  • Patient under any medication or analgesic intake for pain management.
  • Patients with any systemic health issues
  • Patient allergies to trypsin-chymotrypsin, ibuprofen, and paracetamol
  • Pregnancy.
  • Non-restorable teeth.
  • Immature roots.
  • Calcifications.
  • Resorptions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gulf Medical University

Ajman, 4184, United Arab Emirates

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 30, 2024

First Posted

November 4, 2024

Study Start

September 1, 2024

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

November 4, 2024

Record last verified: 2024-11

Locations